linkedin post 2013-06-12 06:02:40

GENE PATENT REPORT affirms the important role that IP played in innovating commercial products, more in the past than now, and importantly, including use not composition of matter patents. I have licensed dozens of these patents during my career. I can absolutely affirm that IP was critical for securing VC funding and for creating a leading diagnostic venture. Unfortunately, players like Myriad pushed the limits so blatantly that the whole debate has been skewed. The compromise may be use patents which even purists should have no objection to, unless they fail to grasp Biz 101.

http://lnkd.in/4eCD5J

View in LinkedIn